Abstract
Inflammatory bowel diseases (IBD) have a complex, multifactorial pathophysiology with an unmet need for effective treatment. This calls for novel strategies to improve disease outcome and quality of life for patients. Increasing evidence suggests that autonomic nerves and neurotransmitters, as well as neuropeptides, modulate the intestinal immune system, and thereby regulate the intestinal inflammatory processes. Although the autonomic nervous system is classically divided in a sympathetic and parasympathetic branch, both play a pivotal role in the crosstalk with the immune system, with the enteric nervous system acting as a potential interface. Pilot clinical trials that employ vagus nerve stimulation to reduce inflammation are met with promising results. In this paper, we review current knowledge on the innervation of the gut, the potential of cholinergic and adrenergic systems to modulate intestinal immunity, and comment on ongoing developments in clinical trials.
Original language | English |
---|---|
Article number | 670 |
Journal | Cells |
Volume | 8 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2 Jul 2019 |
Keywords
- Acetylcholine
- Inflammatory bowel disease
- Innervation
- Nerve stimulation
- Norepinephrine
- Clinical Trials as Topic
- Colon/immunology
- Enteric Nervous System/immunology
- Humans
- Inflammatory Bowel Diseases/immunology
- Intestinal Mucosa/immunology
- Neuroimmunomodulation/immunology
- Treatment Outcome
- Vagus Nerve Stimulation